Founded in 2006, Fast BioMedical Inc. plans to use the money to help advance clinical trials and hire additional workers. It develops technologies to measure blood volume and kidney function.
Around Indiana, life sciences companies are searching high and low for venture capital to fund promising but expensive new products, which can take a decade or longer to develop.
One of the victories, tech leaders said, was the legislative green light for a toll-road fund to invest $250 million in venture capital. But the mechanism for doing so has yet to be determined.
Indiana companies grabbed $27.3 million in venture funding in the first quarter, in line with other recent quarters. But nearly half of that amount went to one firm.
The average amount of venture capital flowing into Indiana companies per deal is the lowest in the Midwest and among the lowest in the country.
Some of Indiana’s most acclaimed technology and entrepreneurial events are joining forces for a multi-day June conference, an effort aimed at boosting venture capital in a state that struggles to draw it.
The Indianapolis-based company plans to use the cash infusion slated to boost its headcount and expand its office space.
AngelBom is composed of alumni of the IU Kelley School of Business’ Business of Medicine Program and is a 6-month-old chapter of the angel investment group VisionTech Partners.
Lumavate sells software to manufacturers so they can give their customers relevant information about products when they need it.
Two local men who have been working on a potential blockbuster treatment for a rare and debilitating disease are hopeful that a major injection of venture capital will provide the boost needed to move the drug to market—even if it means sweeping changes for their company.
The bill would increase the cap on the amount of tax credits investors could claim, as well as make the credits useful for out-of-state investors.
Candidates for initial public offerings are increasingly opting for mergers or private equity instead.
Last year, one research firm pegged Indiana’s 2015 venture capital activity at about $55 million. This year, another firm said it was about $157 million.
Hoosier companies signed 31 venture capital deals worth $77 million last year, a 16-year-high for deal activity that underscores Indiana’s growing variety of high growth firms.
Marketing software maker SmarterHQ Inc. has raised $13 million to expand operations, marking one of the area’s largest venture capital hauls in recent years.
TechPoint CEO Mike Langellier spoke with IBJ about his group’s evolution, his interest in the internet of things, and why elected officials are increasingly paying attention to tech.
Hoosier companies raised about $12.1 million from venture capitalists in the third quarter—a small haul compared to previous quarters, but enough to keep the state on track for a relatively strong year.
Zylo, launched by Indianapolis-based High Alpha Studio earlier this year, received funding from three well-known names in the local tech community.
Indianapolis-based Elevate Ventures said it made the investment through the 21st Century Research & Technology Fund, which is reserved for Indiana companies.
Doxly, a High Alpha Studio company, grabbed the cash in its first fundraising round and signed on the world’s largest law firm as a customer.
